Skip to content

Clinical trials

Phase 1 Uterine Cervical Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20082
20101
20151
20191
20205
20212
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting4
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
AstraZeneca2
Gustave Roussy, Cancer Campus, Grand Paris2
Seagen Inc.2
ARCAGY/ GINECO GROUP1
AbbVie1
Adlai Nortye Biopharma Co., Ltd.1
Alterome Therapeutics, Inc.1
Atavistik Bio, Inc1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms21
Carcinoma, Non-Small-Cell Lung13
Ovarian Neoplasms12
Triple Negative Breast Neoplasms12
Endometrial Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Stomach Neoplasms6
Urinary Bladder Neoplasms6
Esophageal Neoplasms5
Melanoma5

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.